Company intelligence / Profile preview

SynGenis

Bentley, Western Australia, Australiasyngenis.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

SynGenis is an Australian specialist in custom oligonucleotide synthesis, providing high-quality DNA and RNA oligonucleotides—including modified forms—for use in therapeutics, diagnostics, and drug delivery. The company supports both research organizations and commercial clients from R&D through to commercial production. It does not develop its own clinical pipeline but enables others' programs with its products[1][2][5].

Modalities: Synthetic oligonucleotideRNA therapy (enabling)DNA-based tools (enabling)
Industry: Non-Drug Biotech

Partnerships

SpeeDx Pty Ltd

Beyond the preview

Go deeper on SynGenis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SynGenis.

Explore the full profile